Answers are grounded in this paper and cite their sources.
Investigates rapamycin's effect on astrocytomas in young adults, suggesting potential for effective treatment.
The authors present a 21-year-old woman who has been receiving rapamycin for 5 months for bilateral subependymal giant cell astrocytomas. The patient was started at a dose of 0.2 mg/kg/day. Levels were maintained between 11 and 13 ng/mL. Magnetic resonance imaging of the brain 2(1/2) months after initiating rapamycin demonstrated a decrease in size of both astrocytomas (11 to 7.5 mm on the right and 8 to 5 mm on the left). Further studies are needed with prolonged observation to confirm these findings, determine the length of necessary treatment, and evaluate recurrence risk after discontinuation of rapamycin.
No takes yet. Share an insight, caveat, or question.
Koenig et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: